CVS Health — Oct 29, 2025 release

nearly $6.0 billion and retention in the high nineties, highlighting commitment to providing exceptional value and transparency 2025 Full-Year Guidance • Updated GAAP diluted earnings (loss) per share guidance range to $(0.34) to $(0.24) from $3.84 to $3.94 • Raised Adjusted EPS guidance range to $6.55 to $6.65 from $6.30 to $6.40 • Updated cash flow from operations guidance to a range of $7.5 billion to $8.0 billion from at least $7.5 billion CEO Commentary “CVS Health uniquely delivers what the people we serve want the most: a connected, simpler experience that improves health and simplifies care. Our leadership team has stabilized operations and is focused on businesses and markets where we can succeed. As a result, we are making progress on our journey to be America’s most trusted health care company. Our strong Enterprise performance demonstrates the continued focus we have on operational and financial improvement across our businesses.” – David Joyner, CVS Health President and CEO WOONSOCKET, RHODE ISLAND, October 29, 2025 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2025. Financial Results Summary Three Months Ended September 30, In millions, except per share amounts 2025 2024 Change Total revenues $ 102,871  $ 95,428  $ 7,443  Operating income (loss) (3,207) 832  (4,039) Adjusted operating income (1) 3,459  2,547  912  Diluted earnings (loss)